Skip to content

Ultrasound Guided Versus Standard Paravertebral Blockade in Breast Surgery

A Prospective Randomized Controlled Trial of Ultrasound Guided Versus Standard Paravertebral Blockade in Breast Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02623387
Enrollment
100
Registered
2015-12-07
Start date
2015-06-30
Completion date
2016-06-30
Last updated
2015-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional Anaesthesia, Mastectomy, Breast-Conserving Surgery

Keywords

paravertebral block

Brief summary

The aim of this study is to compare conventional and ultrasound guided paravertebral blocks to with respect to efficacy, patient satisfaction and complication rates.

Detailed description

Adequate pain control is important in breast cancer surgery. In addition to benefits to patients, effective pain management strategies also facilitate day case surgery. Regional anaesthetic techniques, and paravertebral blocks in particular, are valuable in this sphere. The conventional method of administering this block is blind and depends on anatomical landmarks for placement. Performing the block under US guidance provides real time imaging while advancing the needle. This might allow for a more accurate placement and hence a more effective block which would enhance pain relief and minimise complications.

Interventions

Paravertebral blocks is a regional anaesthetic technique in which thoracic spinal nerves are inhibited for post operative analgesia in patients undergoing breast surgery. The site of injection can be determined using anatomical landmarks (standard) or using ultrasound guidance.

Sponsors

University College Hospital Galway
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing resectional breast surgery * Benign or malignant indications for surgery

Exclusion criteria

* Previous spinal surgery * Severe coagulopathy * Allergies to local anaesthesia * Localised infection at site of injection

Design outcomes

Primary

MeasureTime frameDescription
Analgesia requirements in 24 hours post op.24hoursNon opiate and opiate analgesia (morphine equivalent) intake at 24hours post op

Secondary

MeasureTime frameDescription
Pain Scores1, 2 and 24 hours post operatively and 1 week post operativelyMeasured on Visual Analogue Scale or Verbal Numerical Rating Scale at 1, 2 and 24 hours post operatively and 1 week
Patient satisfactionUp to 2 weeks post operatively1. Satisfaction Questionnaire 2. SF 36 Questionnaire
ComplicationsUp to 2 weeks post operativelyAny complication of the procedure experienced

Countries

Ireland

Contacts

Primary ContactDeirdre Nally, MCh
deirdrenally@rcsi.ie

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026